Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
Appointed COO
Appointed director
|
|
VERACYTE, INC. (VCYT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2022 |
8-K
| Quarterly results |
| 03/22/2021 |
8-K
| Quarterly results |
| 07/27/2020 |
8-K
| Quarterly results |
| 11/16/2015 |
8-K
| Appointed a new director |
| 01/12/2015 |
8-K
| Appointed a new director |
| 11/13/2014 |
8-K
| Appointed a new director|
Docs:
|
"Veracyte Announces Appointment of John L. Bishop to Its Board of Directors Following the Resignation of Samuel D. Colella South San Francisco, Calif. — November 12, 2014 — Veracyte, Inc. , a molecular diagnostics company pioneering the field of molecular cytology, announced the resignation of Samuel D. Colella from its Board of Directors, effective November 30, 2014. The Veracyte Board accepted his resignation at its November 11, 2014 meeting, during which it also approved the selection of veteran diagnostics executive John L. Bishop to fill the vacancy left by Mr. Colella, effective December 1, 2014. Mr. Bishop will also join the Board's Compensation Committee. “On behalf of Veracyte, I would like to thank Sam for his years of service and significant contributions as a member of the found..." |
|
|
|